PATENT CLAIM ANALYSIS

Application Number: 15979730
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "565000"]

Abstract:
The present invention is directed to novel anti-inflammatory immunomodulators including creatinine or a creatinine salt, for example, creatinine hydrochloride. The present invention is also directed to methods for treating inflammation and inducing an immunomodulatory response. In particular, the anti-inflammatory immunomodulators are useful for treating an inflammatory condition or an autoimmune disease.

Claim (Index 4):
The method of  claim 1 , wherein the immunomodulating agent is present in the composition in an amount of about 15 percent to about 35 percent by weight of the composition.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 93.0
- Lexical Diversity: 1.54054
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14960806', '14844652', '12723003', '10729427', '15133501']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7251193186429764
- 35 USC 102 Novelty (BERT): 0.5567094344624809
- Combined Prediction Score: 0.7082783302249269
- Mean Citation Score: 225.409606
- Max Citation Score: 415.32996
- Similarity Product: 291.37028028279315

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test